Knowledge

Carcinocythemia

Source 📝

40: 185:
are frequently reported in association with carcinocythemia. The prognosis is poor: a review of 26 patients found that 85% died within 6 months of the diagnosis, with an average time of 6.1 weeks between diagnosis and death.
189:
The amount of tumour cells on the blood smear can range from 1 to 80 percent of the total white blood cell count, with lower percentages being more common. Carcinocythemia is distinct from the presence of
765:
Chang, Yuan-Hsin; Hsieh, Ruey-Kuen; Chang, Ming-Chi; Chen, Gon-Shen (2007). "Breast cancer with an unusual leukemia-like presentation: case report and literature review".
153:. It is an extremely rare condition, with 33 cases identified in the literature from 1960 to 2018. Carcinocythemia typically occurs secondary to infiltration of the 264:. Tumour cells are often found at the edge of the blood smear due to their large size, so this area should be examined thoroughly if carcinocythemia is suspected. 972:
Sá e Lemos, Eva; Lima de Carvalho, Hugo; Gil da Costa, Rui M.; Pinto da Cunha, Nazaré (2018). "Carcinocythemia: First report in a cat and literature review".
194:(CTCs), as CTCs usually occur in such low quantities that they cannot be seen on blood smear examination, requiring special techniques for detection. 847: 685: 657: 658:
Michael Caligiuri; Marcel M. Levi; Kenneth Kaushansky; Marshall A. Lichtman, Josef Prchal, Linda J Burns, Oliver W Press (23 December 2015).
941: 924: 861:
Ashworth, T.R. (1869). "(1869) A Case of Cancer in Which Cells Similar to Those in the Tumours Were Seen in the Blood after Death".
389:
Ogura, Kanako; Amano, Maki; Matsumoto, Toshiharu; Sakaguchi, Asumi; Kosaka, Taijiro; Kitabatake, Toshiaki; Kojima, Kuniaki (2015).
573:"Carcinocythemia: A rare entity becoming more common? A 3-year, single institution series of seven cases and literature review" 182: 880:
Carey, Robert W.; Taft, Priscilla D.; Bennett, John M.; Kaufman, Sheldon (1976). "Carcinocythemia (carcinoma cell leukemia)".
669: 642: 530: 365:
was first used in 1976 by Robert Carey. In 1984, a review of 10 cases was published, noting the condition's poor prognosis.
39: 355:
The presence of tumour cells in the peripheral blood of a cancer patient was first described in an 1869 case report in the
291: 1017: 245:
cells. Features that aid in distinguishing tumour cells from other cells include their very large size, mature
290:, a profile that is non-specific but unusual for hematologic malignancies. In some cases, flow cytometry and 357: 256:, and their tendency to appear in clumps or clusters, although some of these characteristics are shared by 202:
The mechanism of carcinocythemia is poorly understood. Some patients with carcinocythemia show evidence of
207: 571:
Ronen, Shira; Kroft, Steven H.; Olteanu, Horatiu; Hosking, Paul R.; Harrington, Alexandra M. (2019).
1032: 191: 815: 301: 1042: 925:"Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review" 632: 174: 150: 87: 518: 373:
As of 2018, there were two documented cases of carcinocythemia in dogs and one case in a cat.
841: 391:"Occult Breast Lobular Carcinoma with Numerous Circulating Tumor Cells in Peripheral Blood" 271: 8: 227: 798: 738: 679: 630: 610: 425: 390: 341: 267: 100: 1037: 997: 989: 954: 946: 905: 897: 893: 829: 790: 782: 730: 722: 665: 638: 602: 594: 526: 484: 476: 430: 412: 275: 158: 76: 56: 971: 802: 742: 614: 981: 936: 889: 774: 712: 584: 466: 420: 402: 328: 214:
of malignant cells, could contribute to the presence of tumour cells in the blood.
108: 659: 471: 454: 942:
10.1002/1097-0142(19840301)53:5<1100::AID-CNCR2820530514>3.0.CO;2-K
316: 279: 257: 146: 92: 778: 1026: 993: 950: 901: 786: 726: 631:
Noel Weidner; Richard J. Cote; Saul Suster; Lawrence M. Weiss (8 July 2009).
598: 480: 416: 332: 230:. If the number of suspicious cells is low, a smear can be prepared from the 170: 112: 48: 1001: 794: 734: 606: 488: 434: 322: 211: 203: 104: 1018:
Images of carcinocythemia at the American Society of Hematology image bank
958: 909: 833: 817: 816:
Lugassy G, Vorst EJ, Varon D, Sigler E, Shani A, Bassous-Guedj L. (1990).
516: 407: 818:"Carcinocythemia. Report of two cases, one simulating a Burkitt lymphoma" 304:
is indicated in carcinocythemia to better characterize the tumour cells.
295: 250: 223: 154: 80: 717: 700: 589: 572: 336: 238: 231: 178: 116: 61: 985: 312:
Carcinocythemia must be distinguished from the following conditions:
261: 253: 246: 123: 298:
and chromosomal abnormalities associated with hematologic diseases.
294:
results may be misleading, as circulating tumour cells can exhibit
242: 96: 65: 517:
Irma Pereira; Tracy I. George; Daniel A. Arber (7 December 2011).
237:
Tumour cells in peripheral blood may look similar to circulating
701:"The emerging role of circulating tumor cells in breast cancer" 142: 274:
techniques can help determine the lineage of the cells. When
388: 287: 283: 177:, and usually appears late in the course of the disease. 570: 879: 523:
Atlas of Peripheral Blood: The Primary Diagnostic Tool
47:
A case of carcinocythemia. The large, round cells are
525:. Lippincott Williams & Wilkins. pp. 185–7. 206:, and it has been suggested that dysfunction of the 764: 452: 916: 519:"Chapter 20: Nonhematopoietic tumors in the blood" 923:Gallivan, Monica V. E.; Lokich, Jacob J. (1984). 626: 624: 566: 564: 562: 453:Johnsrud, Andrew J.; Pina-Oviedo, Sergio (2017). 1024: 760: 758: 756: 754: 752: 692: 651: 560: 558: 556: 554: 552: 550: 548: 546: 544: 542: 141:, is a condition in which cells from malignant 922: 621: 577:International Journal of Laboratory Hematology 448: 446: 444: 234:of the blood sample to concentrate the cells. 873: 749: 698: 539: 512: 510: 508: 506: 504: 502: 500: 498: 382: 222:Carcinocythemia can be detected on a routine 965: 854: 846:: CS1 maint: multiple names: authors list ( 684:: CS1 maint: multiple names: authors list ( 637:. Elsevier Health Sciences. pp. 1593–. 455:"Carcinocythemia (carcinoma cell leukemia)" 441: 809: 495: 51:cells circulating in the peripheral blood. 38: 940: 716: 588: 470: 424: 406: 307: 860: 321:Circulating immature cells secondary to 169:Carcinocythemia occurs most commonly in 1025: 664:. McGraw-Hill Education. p. 658. 183:disseminated intravascular coagulation 161:and carries a very poor prognosis. 128:Poor; 15% survival rate at 6 months 13: 103:, circulating immature cells from 14: 1054: 1011: 882:The American Journal of Medicine 863:The Medical Journal of Australia 368: 699:Krishnamurthy, Savitri (2012). 164: 1: 974:Veterinary Clinical Pathology 376: 894:10.1016/0002-9343(76)90437-X 472:10.1182/blood-2017-08-799882 358:Medical Journal of Australia 217: 197: 7: 16:Tumour cells on blood smear 10: 1059: 350: 282:, the cells are generally 208:reticuloendothelial system 149:origin are visible on the 779:10.1007/s12032-007-0048-2 634:Modern Surgical Pathology 395:Case Reports in Pathology 286:negative and may express 122: 86: 71: 55: 46: 37: 29: 24: 204:impaired spleen function 192:circulating tumour cells 661:Williams Hematology, 9E 302:Bone marrow examination 139:carcinoma cell leukemia 33:Carcinoma cell leukemia 308:Differential diagnosis 175:small cell lung cancer 151:peripheral blood smear 88:Differential diagnosis 268:Cytochemical staining 75:Usually secondary to 705:Cancer Cytopathology 272:immunohistochemistry 408:10.1155/2015/135684 228:manual differential 718:10.1002/cncy.20207 590:10.1111/ijlh.12924 342:Leukemoid reaction 101:leukemoid reaction 986:10.1111/vcp.12565 671:978-0-07-183300-4 644:978-1-4377-1958-1 532:978-1-4511-6366-7 329:endothelial cells 247:nuclear chromatin 159:metastatic cancer 132: 131: 109:endothelial cells 77:metastatic cancer 19:Medical condition 1050: 1006: 1005: 969: 963: 962: 944: 935:(5): 1100–1102. 920: 914: 913: 877: 871: 870: 858: 852: 851: 845: 837: 813: 807: 806: 767:Medical Oncology 762: 747: 746: 720: 696: 690: 689: 683: 675: 655: 649: 648: 628: 619: 618: 592: 568: 537: 536: 514: 493: 492: 474: 450: 439: 438: 428: 410: 386: 276:immunophenotyped 137:, also known as 42: 22: 21: 1058: 1057: 1053: 1052: 1051: 1049: 1048: 1047: 1033:Hematopathology 1023: 1022: 1014: 1009: 970: 966: 921: 917: 878: 874: 859: 855: 839: 838: 814: 810: 763: 750: 697: 693: 677: 676: 672: 656: 652: 645: 629: 622: 569: 540: 533: 515: 496: 451: 442: 387: 383: 379: 371: 363:carcinocythemia 353: 310: 258:megakaryoblasts 226:examination or 220: 200: 167: 135:Carcinocythemia 25:Carcinocythemia 20: 17: 12: 11: 5: 1056: 1046: 1045: 1040: 1035: 1021: 1020: 1013: 1012:External links 1010: 1008: 1007: 980:(1): 142–145. 964: 915: 888:(2): 273–278. 872: 853: 808: 773:(1): 100–103. 748: 711:(3): 161–166. 691: 670: 650: 643: 620: 538: 531: 494: 440: 380: 378: 375: 370: 367: 352: 349: 348: 347: 344: 339: 333:megakaryocytes 325: 319: 317:Acute leukemia 309: 306: 280:flow cytometry 219: 216: 199: 196: 173:, followed by 166: 163: 130: 129: 126: 120: 119: 113:megakaryocytes 107:, circulating 93:Acute leukemia 90: 84: 83: 73: 69: 68: 59: 53: 52: 44: 43: 35: 34: 31: 27: 26: 18: 15: 9: 6: 4: 3: 2: 1055: 1044: 1043:Rare diseases 1041: 1039: 1036: 1034: 1031: 1030: 1028: 1019: 1016: 1015: 1003: 999: 995: 991: 987: 983: 979: 975: 968: 960: 956: 952: 948: 943: 938: 934: 930: 926: 919: 911: 907: 903: 899: 895: 891: 887: 883: 876: 868: 864: 857: 849: 843: 835: 831: 827: 823: 819: 812: 804: 800: 796: 792: 788: 784: 780: 776: 772: 768: 761: 759: 757: 755: 753: 744: 740: 736: 732: 728: 724: 719: 714: 710: 706: 702: 695: 687: 681: 673: 667: 663: 662: 654: 646: 640: 636: 635: 627: 625: 616: 612: 608: 604: 600: 596: 591: 586: 582: 578: 574: 567: 565: 563: 561: 559: 557: 555: 553: 551: 549: 547: 545: 543: 534: 528: 524: 520: 513: 511: 509: 507: 505: 503: 501: 499: 490: 486: 482: 478: 473: 468: 464: 460: 456: 449: 447: 445: 436: 432: 427: 422: 418: 414: 409: 404: 400: 396: 392: 385: 381: 374: 369:Other animals 366: 364: 360: 359: 345: 343: 340: 338: 334: 330: 326: 324: 320: 318: 315: 314: 313: 305: 303: 299: 297: 293: 289: 285: 281: 277: 273: 269: 265: 263: 259: 255: 252: 248: 244: 240: 235: 233: 229: 225: 215: 213: 210:, preventing 209: 205: 195: 193: 187: 184: 180: 176: 172: 171:breast cancer 162: 160: 156: 152: 148: 147:hematopoietic 144: 140: 136: 127: 125: 121: 118: 114: 110: 106: 102: 98: 94: 91: 89: 85: 82: 78: 74: 70: 67: 63: 60: 58: 54: 50: 49:breast cancer 45: 41: 36: 32: 28: 23: 977: 973: 967: 932: 928: 918: 885: 881: 875: 866: 862: 856: 842:cite journal 828:(2): 265–8. 825: 821: 811: 770: 766: 708: 704: 694: 660: 653: 633: 583:(1): 69–79. 580: 576: 522: 465:(21): 2357. 462: 458: 398: 394: 384: 372: 362: 356: 354: 327:Circulating 323:chemotherapy 311: 300: 296:cell markers 266: 236: 221: 212:phagocytosis 201: 188: 168: 165:Presentation 138: 134: 133: 105:chemotherapy 361:. The term 337:osteoclasts 224:blood smear 155:bone marrow 117:osteoclasts 81:bone marrow 30:Other names 1027:Categories 869:: 146–147. 822:Acta Cytol 377:References 262:monoblasts 251:vacuolated 249:pattern, 232:buffy coat 179:Thrombosis 62:Hematology 994:0275-6382 951:0008-543X 902:0002-9343 787:1357-0560 727:1934-662X 680:cite book 599:1751-5521 481:0006-4971 417:2090-6781 254:cytoplasm 218:Diagnosis 198:Mechanism 124:Prognosis 57:Specialty 1038:Leukemia 1002:29360147 803:20417675 795:18188722 743:36422597 735:22275137 615:52278041 607:30216684 489:29170195 435:26199779 346:Lymphoma 243:lymphoma 97:lymphoma 66:oncology 959:6362836 910:1062163 834:2157324 426:4496473 401:: 1–6. 351:History 145:of non- 143:tumours 79:in the 1000:  992:  957:  949:  929:Cancer 908:  900:  832:  801:  793:  785:  741:  733:  725:  668:  641:  613:  605:  597:  529:  487:  479:  433:  423:  415:  239:blasts 72:Causes 799:S2CID 739:S2CID 611:S2CID 459:Blood 998:PMID 990:ISSN 955:PMID 947:ISSN 906:PMID 898:ISSN 848:link 830:PMID 791:PMID 783:ISSN 731:PMID 723:ISSN 686:link 666:ISBN 639:ISBN 603:PMID 595:ISSN 527:ISBN 485:PMID 477:ISSN 431:PMID 413:ISSN 399:2015 292:FISH 288:CD56 284:CD45 270:and 260:and 181:and 982:doi 937:doi 890:doi 775:doi 713:doi 709:120 585:doi 467:doi 463:130 421:PMC 403:doi 335:or 278:by 241:or 157:by 115:or 1029:: 996:. 988:. 978:47 976:. 953:. 945:. 933:53 931:. 927:. 904:. 896:. 886:60 884:. 867:14 865:. 844:}} 840:{{ 826:34 824:. 820:. 797:. 789:. 781:. 771:25 769:. 751:^ 737:. 729:. 721:. 707:. 703:. 682:}} 678:{{ 623:^ 609:. 601:. 593:. 581:41 579:. 575:. 541:^ 521:. 497:^ 483:. 475:. 461:. 457:. 443:^ 429:. 419:. 411:. 397:. 393:. 331:, 111:, 99:, 95:, 64:, 1004:. 984:: 961:. 939:: 912:. 892:: 850:) 836:. 805:. 777:: 745:. 715:: 688:) 674:. 647:. 617:. 587:: 535:. 491:. 469:: 437:. 405::

Index


breast cancer
Specialty
Hematology
oncology
metastatic cancer
bone marrow
Differential diagnosis
Acute leukemia
lymphoma
leukemoid reaction
chemotherapy
endothelial cells
megakaryocytes
osteoclasts
Prognosis
tumours
hematopoietic
peripheral blood smear
bone marrow
metastatic cancer
breast cancer
small cell lung cancer
Thrombosis
disseminated intravascular coagulation
circulating tumour cells
impaired spleen function
reticuloendothelial system
phagocytosis
blood smear

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.